vs
Side-by-side financial comparison of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) and Virgin Galactic Holdings, Inc (SPCE). Click either name above to swap in a different company.
Virgin Galactic Holdings, Inc is the larger business by last-quarter revenue ($4.2M vs $2.9M, roughly 1.5× NEUROONE MEDICAL TECHNOLOGIES Corp). NEUROONE MEDICAL TECHNOLOGIES Corp runs the higher net margin — -49.7% vs -2222.2%, a 2172.4% gap on every dollar of revenue. On growth, Virgin Galactic Holdings, Inc posted the faster year-over-year revenue change (125.5% vs -11.7%). NEUROONE MEDICAL TECHNOLOGIES Corp produced more free cash flow last quarter ($-3.2M vs $-113.5M).
NeuroOne Medical Technologies Corp is a medical technology company specializing in the development and commercialization of diagnostic and therapeutic neurological devices for conditions including epilepsy, movement disorders, and chronic pain. Its core products include minimally invasive cortical monitoring electrodes and neurostimulation systems, primarily serving neurology and neurosurgical care providers across North America.
Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.
NMTC vs SPCE — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $2.9M | $4.2M |
| Net Profit | $-1.4M | $-93.8M |
| Gross Margin | 54.2% | -546.6% |
| Operating Margin | -59.0% | -2412.1% |
| Net Margin | -49.7% | -2222.2% |
| Revenue YoY | -11.7% | 125.5% |
| Net Profit YoY | -180.5% | 30.2% |
| EPS (diluted) | $-0.03 | $-4.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $1.7M | — | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $272.3K | — | ||
| Q2 24 | $825.8K | $4.2M | ||
| Q1 24 | $1.4M | $2.0M |
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-2.8M | $-93.8M | ||
| Q1 24 | $-2.9M | $-102.0M |
| Q4 25 | 54.2% | — | ||
| Q3 25 | 55.8% | — | ||
| Q2 25 | 53.9% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 51.8% | — | ||
| Q2 24 | 34.1% | -546.6% | ||
| Q1 24 | 28.3% | -1038.1% |
| Q4 25 | -59.0% | — | ||
| Q3 25 | -50.0% | — | ||
| Q2 25 | -111.2% | — | ||
| Q1 25 | -193.3% | — | ||
| Q4 24 | 52.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -338.3% | -2412.1% | ||
| Q1 24 | -209.5% | -5599.9% |
| Q4 25 | -49.7% | — | ||
| Q3 25 | -59.1% | — | ||
| Q2 25 | -88.5% | — | ||
| Q1 25 | -163.8% | — | ||
| Q4 24 | 54.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -335.1% | -2222.2% | ||
| Q1 24 | -207.3% | -5139.1% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.10 | $-4.36 | ||
| Q1 24 | $-0.11 | $-5.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $775.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.4M | $394.8M |
| Total Assets | $8.6M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | — | ||
| Q3 25 | $6.6M | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.6M | $775.7M | ||
| Q1 24 | $2.4M | $765.2M |
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.1M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $822.0K | — | ||
| Q2 24 | $3.0M | $394.8M | ||
| Q1 24 | $3.9M | $417.6M |
| Q4 25 | $8.6M | — | ||
| Q3 25 | $10.8M | — | ||
| Q2 25 | $10.8M | — | ||
| Q1 25 | $4.5M | — | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $5.4M | — | ||
| Q2 24 | $4.9M | $1.1B | ||
| Q1 24 | $5.4M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.1M | $-79.1M |
| Free Cash FlowOCF − Capex | $-3.2M | $-113.5M |
| FCF MarginFCF / Revenue | -109.1% | -2690.7% |
| Capex IntensityCapex / Revenue | 1.4% | 815.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-458.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.1M | — | ||
| Q3 25 | $-1.5M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-56.1K | — | ||
| Q4 24 | $208.0K | — | ||
| Q3 24 | $-11.0M | — | ||
| Q2 24 | $-2.4M | $-79.1M | ||
| Q1 24 | $-2.2M | $-113.2M |
| Q4 25 | $-3.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $183.6K | — | ||
| Q3 24 | $-11.1M | — | ||
| Q2 24 | $-2.4M | $-113.5M | ||
| Q1 24 | $-2.2M | $-126.3M |
| Q4 25 | -109.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -89.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | -4088.4% | — | ||
| Q2 24 | -287.6% | -2690.7% | ||
| Q1 24 | -160.2% | -6362.8% |
| Q4 25 | 1.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 44.1% | — | ||
| Q2 24 | 1.8% | 815.5% | ||
| Q1 24 | 2.3% | 658.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
